戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              TSC also dampens the intensity of an ischemic challenge
2                                              TSC and apparent diffusion coefficient (ADC) were calcul
3                                              TSC astrocytes appeared epithelial (i.e. tightly adheren
4                                              TSC differed between 9.63 and 29.47%.
5                                              TSC has a wide variety of clinical and radiologic manife
6                                              TSC improves the diffusion of oxygen and glucose, and in
7                                              TSC is associated with autism, intellectual disability a
8                                              TSC is found to be more effective additive in order to m
9                                              TSC patients with autism display impairments in white ma
10                                              TSC values in normal glandular and adipose breast tissue
11 t-like cells from 29 TSC skin tumors from 22 TSC subjects and identified germline and second-hit muta
12        We grew fibroblast-like cells from 29 TSC skin tumors from 22 TSC subjects and identified germ
13 and HIC-5 (also known as HIC5, ARA55, HIC-5, TSC-5, and TGFB1I1).
14 iolet 'signature' mutations, never seen as a TSC germline mutation.
15 ciated with newly formed axons, indicating a TSC-dependence of lanceolate complex maintenance and reg
16  size, 14 mm +/- 12; range, 6-35 mm), with a TSC of 47 mmol/kg +/- 8 (P = .002).
17                                Additionally, TSC reduced edema and hemorrhagic volume in a rat model
18  branch, independent of the conventional Akt/TSC/Rheb signaling axis.
19         These findings indicate that not all TSCs function as ZMCs, and much of their activity can be
20 erilisation than to UHT processing, although TSC addition increased the sediment formed by UHT proces
21                                      ADC and TSC were inversely correlated (r = -0.881, P < .001).
22 ng and cell survival independent of AMPK and TSC.
23 amounts of total phenolics, anthocyanins and TSC were selected for further breeding purposes to provi
24 ncreased with higher amounts of added CA and TSC in extruded rice.
25 ntainer sterilisation, while adding DSHP and TSC made the milk more unstable during in-container ster
26 tors, we show that embryogenesis of ESC- and TSC-derived embryos-ETS-embryos-depends on cross-talk in
27 thways may have therapeutic value in LAM and TSC-related diseases, and possibly in other conditions a
28  therapeutic target for treatment of LAM and TSC.
29 identify a new interplay between the PKD and TSC genes, with important implications for the pathophys
30 in accessibility at key genes upregulated as TSCs exit from the stem cell state.
31                                     The ASRS TSC encourages active postmarketing surveillance by all
32 ces throughout the United States to the ASRS TSC from December 1, 2011, through February 12, 2014.
33  recruits Tfap2c to triply occupied sites at TSC-specific genes, driving their expression.
34 lecular switch governing the balance between TSC proliferation and differentiation.
35  circuits to govern the fine balance between TSC self-renewal and differentiation.
36 endent role of Elf5 at the interface between TSC self-renewal and the onset of differentiation.
37 tors are largely unknown in the human brain, TSC patient cortical tubers were used to uncover hyperph
38 ing Syk in this and other settings driven by TSC genetic mutation.
39 tomated gait analysis, also were improved by TSC treatment.
40 ne relieves allosteric inhibition of Rheb by TSC.
41  the close physical proximity of FePP and CA/TSC in the extruded rice matrix.
42 als (3.2%) than from No CA/TSC (1.7%) and CA/TSC solution (1.7%; all P < 0.05) and was not different
43 uded rice than in rice with No CA/TSC and CA/TSC solution, and solubility increased with higher amoun
44 ition of a citric acid/trisodium citrate (CA/TSC) mixture before extrusion increases iron absorption
45  absorption was significantly higher from CA/TSC-extruded meals (3.2%) than from No CA/TSC (1.7%) and
46 lubility and dialyzability were higher in CA/TSC-extruded rice than in rice with No CA/TSC and CA/TSC
47 CA/TSC-extruded meals (3.2%) than from No CA/TSC (1.7%) and CA/TSC solution (1.7%; all P < 0.05) and
48 CA/TSC-extruded rice than in rice with No CA/TSC and CA/TSC solution, and solubility increased with h
49  Iron bioavailability nearly doubled when CA/TSC was extruded with FePP into fortified rice, resultin
50  dialyzable iron from rice meals in which CA/TSC was added at different preparation stages and from m
51 stages and from meals with different iron:CA:TSC ratios.
52            We propose a 2-stage calibration (TSC) method, which summarizes the confounding informatio
53           India's Total Sanitation Campaign (TSC) is one such program that seeks to end the practice
54 GC-1beta pathway-separate from the canonical TSC-mTOR-S6K pathway-that regulates browning of adipose
55             Takotsubo stress cardiomyopathy (TSC) is a syndrome characterized by transient myocardial
56 at 2 d after surgery, with over 85% CD146(+) TSCs expressing IL-10.
57 d expression of IL-10 and TIMP-3 in CD146(+) TSCs are regulated by JNK/signal transducer and activato
58 oprotease (TIMP)-3 was expressed in CD146(+) TSCs at 1 wk with CTGF, in contrast to control with no T
59 eta that is significantly higher in CD146(+) TSCs compared to CD146(-) tendon cells.
60 nd CTGF and significantly higher in CD146(+) TSCs than CD146(-) tendon cells.
61 gnificantly increased the number of CD146(+) TSCs, leading to enhanced healing.
62 k of a representative trophoblast stem cell (TSC) model with the capacity for self-renewal and the ab
63 where it reinforces a trophoblast stem cell (TSC)-specific transcriptional circuit.
64  and aggresiveness of tumor stem-like cells (TSCs) expressing IGF1 receptor (IGF1R).
65                Tendon stem/progenitor cells (TSCs) have been found in different anatomic locations an
66                      Terminal Schwann cells (TSCs) are key components of the mammalian neuromuscular
67 uscle membranes, and terminal Schwann cells (TSCs) that cover the nerve-muscle contact.
68 and their associated terminal Schwann cells (TSCs).
69                      Trophoblast stem cells (TSCs) are derived from the early mouse embryo and can su
70 d differentiation of trophoblast stem cells (TSCs) are key factors for proper placental development a
71                      Trophoblast stem cells (TSCs) arise from the first cell fate decision in the dev
72                      Trophoblast stem cells (TSCs) give rise to specialized cell types within the pla
73 ) and extraembryonic trophoblast stem cells (TSCs) in a three-dimensional scaffold to generate struct
74  ablation of Gmnn in trophoblast stem cells (TSCs) proliferating in the presence of FGF4 closely mimi
75                      Trophoblast stem cells (TSCs) retain the capacity to self-renew indefinitely and
76 ein EED in F1 hybrid trophoblast stem cells (TSCs), which undergo imprinted inactivation of the pater
77 converts naive tumor cells to chemoresistant TSCs, thereby facilitating their invasiveness and progre
78 odium tartarate (DST) and trisodium citrate (TSC) in the temperature range (288.15-318.15)K from the
79 hosphate (DSHP, 10mM) and trisodium citrate (TSC, 10mM).
80 e shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapamycin (mTOR) and the
81 nitrosylation of tuberous sclerosis complex (TSC) 2, and inhibited dimerization of TSC2 with its inhi
82 atient with both tuberous sclerosis complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cel
83 sorders, such as tuberous sclerosis complex (TSC) and sporadic lymphangioleiomyomatosis.
84 isorders such as tuberous sclerosis complex (TSC) and sporadic lymphangioleiomyomatosis.
85    Patients with tuberous sclerosis complex (TSC) frequently develop collagenous connective tissue ne
86  by mutations in tuberous sclerosis complex (TSC) genes and is associated with insulin resistance, de
87 ing mutations in tuberous sclerosis complex (TSC) genes, and recruit abundant stromal cells.
88 isease (PKD) and tuberous sclerosis complex (TSC) genes.
89  pathogenesis of tuberous sclerosis complex (TSC) have not yet been studied.
90                  Tuberous sclerosis complex (TSC) is a disorder arising from mutation in the TSC1 or
91                  Tuberous sclerosis complex (TSC) is a genetic disease associated with epilepsy and a
92                  Tuberous sclerosis complex (TSC) is a genetic disorder characterized by seizures and
93                  Tuberous sclerosis complex (TSC) is a genetic multiorgan disorder characterized by t
94                  Tuberous sclerosis complex (TSC) is a pediatric disorder of dysregulated growth and
95                  Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder causing benig
96                  Tuberous sclerosis complex (TSC) is a rare genetic disease causing multisystem growt
97                  Tuberous Sclerosis Complex (TSC) is a rare genetic disorder that results from a muta
98                  Tuberous sclerosis complex (TSC) is an autosomal dominant tumor-suppressor gene synd
99                  Tuberous sclerosis complex (TSC) is caused by mutations in the TSC1 and TSC2 tumor s
100                  Tuberous sclerosis complex (TSC) is characterized by the formation of tumors in mult
101 re a hallmark of tuberous sclerosis complex (TSC) manifestations; however, the genesis of these abnor
102 overexpressed in tuberous sclerosis complex (TSC) mice, a PI3K-mTOR model of neurodevelopmental disea
103 rowth factor and tuberous sclerosis complex (TSC) signaling, is driven by RagC/D, and is separable fr
104 mutations in the tuberous sclerosis complex (TSC) tumor suppressor genes are associated closely with
105      Loss of the tuberous sclerosis complex (TSC) tumor suppressors results in activation of mTORC1 a
106 with loss of the tuberous sclerosis complex (TSC) tumor suppressors, which exhibit growth factor-inde
107 ific deletion of tuberous sclerosis complex (TSC), a major upstream inhibitor of mTOR, surprisingly a
108 nd Tsc2 form the tuberous sclerosis complex (TSC), a regulator of mTOR activity.
109 ssors underlying tuberous sclerosis complex (TSC), and generated a SS/L network for TSC.
110                  Tuberous sclerosis complex (TSC), caused by dominant mutations in either TSC1 or TSC
111 een R2TP and the tuberous sclerosis complex (TSC), pointing to a potential link between growth signal
112 ode the proteins tuberous sclerosis complex (TSC)-1 and TSC2, which are directly involved in suppress
113 (ASD), including tuberous sclerosis complex (TSC).
114  some women with tuberous sclerosis complex (TSC).
115 orders including tuberous sclerosis complex (TSC).
116 ancer and causes tuberous sclerosis complex (TSC).
117 suppressor genes tuberous sclerosis complex (TSC)1 or TSC2.
118 ion of absolute tissue sodium concentration (TSC), an external phantom was used.
119 ividual anthocyanin and total sugar content (TSC) of wide range of plum cultivars was done in order t
120 minals at hair follicles while, in contrast, TSCs remain associated with hair follicles following ski
121                    Trans-sodium crocetinate (TSC) is a novel carotenoid compound capable of enhancing
122        Here, perovskite thin-single-crystal (TSC) photodetectors are fabricated with a vertical p-i-n
123  have been analyzed, of whom 13 had definite TSC, whereas another 7 had a possible TSC diagnosis.
124           Forty-eight patients with definite TSC (41 women; mean age, 35 years +/- 11 [standard devia
125 entification rate for patients with definite TSC was 85%, but only 29% for the ones with a possible T
126 he current findings demonstrate that delayed TSC treatment improves outcomes in experimental models o
127 rofiles highly similar to blastocyst-derived TSCs, with comparable methylation and H3K27ac patterns a
128 methylation patterns with blastocyst-derived TSCs.
129 xpression and chromatin accessibility during TSC differentiation.
130 n unusual biphasic expression profile during TSC differentiation and thus may be pivotal in balancing
131                                    Eed (-/-) TSCs lack H3K27me3 and Xist lncRNA enrichment on the ina
132  inactive X-linked genes in WT and Eed (-/-) TSCs suggests that PRC2 acts as a brake to prevent induc
133 2 targets that remain repressed in Eed (-/-) TSCs are depleted for active chromatin characteristics i
134 d X-linked genes is derepressed in Eed (-/-) TSCs.
135 a classical biallelic inactivation of either TSC genes (TSC1, hamartin or TSC2, tuberin), an event th
136                           The first (female) TSC patient had a left followed by a right nephrectomy a
137  variable presentations can be important for TSC diagnosis.
138 ng for CAD risk factors and risk markers for TSC.
139 plex (TSC), and generated a SS/L network for TSC.
140 teric modulators (an mGluR5 NAM and PAM) for TSC, using a mutant mouse model with neuronal loss of Ts
141 s and that HMGA2 activation was required for TSC mesenchymal tumorigenesis in genetically engineered
142       Our findings reveal a complex role for TSC in oligodendrocytes during remyelination in which th
143  serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.
144  could be a promising therapeutic target for TSC-associated tumors.
145 allin may complement the current therapy for TSC.
146                           We tested all four TSCs in a number of cell-based assays to examine mutant
147 ion, we found that stem cells generated from TSC patients had a very high rate of integration of the
148  models and in cortical tubers resected from TSC patients.
149                                 Genetically, TSC is said to occur through a classical biallelic inact
150  the transcription factor networks governing TSC identity and opportunities for studying the epigenet
151 uppress IGFBP7, and this stimulates IGF1R(+) TSCs to express FGF4, inducing a feedforward FGFR1-ETS2
152 on of genes whose translation is abnormal in TSC may provide insights to previously unidentified ther
153 sis, which was also increased at baseline in TSC-deficient cells and was not affected by rapamycin tr
154     The role of mesenchymal-derived cells in TSC tumorigenesis was investigated through disruption of
155 chondrial damage, and necrotic cell death in TSC-deficient cells in a highly synergistic and cell con
156 To study aberrations of early development in TSC, we generated induced pluripotent stem cells using d
157 mising molecular target to treat epilepsy in TSC patients.
158 he mechanism of somatic second-hit events in TSC tumors is unknown.
159 uggest that measures to limit UV exposure in TSC children and adults should reduce the frequency and
160 shed the rapamycin-induced uPA expression in TSC-compromised cells.
161  a result of mutations in TSC1/TSC2 genes in TSC patients, because we observed the reactivation of ma
162 ntributes to altered neuronal homeostasis in TSC disease.
163 ostaglandin production was also increased in TSC-deficient cells.
164                  Galectin-3 was increased in TSC-related skin tumors, angiomyolipomas, and lymphangio
165 ions for the effects of mTORC1 inhibitors in TSC, cancers, and the many other disease settings influe
166 ignalling has not been fully investigated in TSC-associated tumours and it has been uncertain whether
167 strates of these disabling manifestations in TSC.
168 ligodendrocyte maturation and myelination in TSC.
169 ful therapeutic potential for mGluR5 NAMs in TSC, which warrants clinical exploration and the continu
170 we identify significant neuroinflammation in TSC-associated brain tumours.
171  and TSC2 mutational analysis carried out in TSC patients in Greece.
172 re employed to promote tumor pathogenesis in TSC and identify a novel, critical pathway for potential
173 ibutes to pathologic dendritic patterning in TSC in an mTOR-independent, ERK1/2-dependent manner.
174 e first detailed genetic analysis of RCCs in TSC patients.
175 uppressed by the RIP1/RIP3/MLKL signaling in TSC-deficient cells, and could be a promising therapeuti
176  addition, modulation of Sox21 expression in TSCs affected lineage-specific differentiation, based on
177 ression and CRISPR/Cas9-mediated knockout in TSCs showed that high Plet1 levels favour differentiatio
178 shift in preferred Elf5-binding partners; in TSCs, Elf5 interaction with Eomes recruits Tfap2c to tri
179 lysis revealed a high expression of Sox21 in TSCs compared with other cell types.
180 hair follicles are tiled and that individual TSCs host axonal endings of more than one LTMR subtype.
181 al tail-tip-derived fibroblasts into induced TSCs (iTSCs) and surmount the epigenetic barrier separat
182 yolipoma cells, but not in cells with intact TSC.
183  report reprogramming mouse fibroblasts into TSCs, surmounting the first lineage barrier established
184 synergizes with BSO and auranofin in killing TSC-deficient cells.
185 th tuberous sclerosis complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cells (iPSC), fol
186                             This could limit TSC-associated tumour growth but lead to paradoxical pro
187                            The second (male) TSC patient had bilateral partial nephrectomies (both at
188 as achieved, with high reproducibility (mean TSC values +/- standard deviation for the test, 36 mmol
189 sion was detected in 100% of human and mouse TSC tumors and that HMGA2 activation was required for TS
190               Both kidneys showed multifocal TSC-associated papillary RCC (PRCC).
191                            To identify novel TSC-specific genes, we performed genome-wide expression
192 arcinoma (RCC) occurs in approximately 3% of TSC patients, and typically develops at age <50.
193  Taken together, this molecular catalogue of TSC serves as a resource into the origin of these hamart
194 e of second-hit mutations and development of TSC facial angiofibromas and suggest that measures to li
195 ged >/= 3 years with a definite diagnosis of TSC and increasing SEGA lesion size (>/=2 magnetic reson
196 ations can be important for the diagnosis of TSC.
197 on of mTORC1 through the combined effects of TSC and RHEB as part of a multiprotein complex localized
198                               The effects of TSC were also tested in a rat model of intracerebral hem
199 s not fully overcome following expression of TSC-determining factors in embryonic stem cells.
200                          Thus, some forms of TSC could be treated with PKCe inhibitors, while metasta
201                     However, the function of TSC has not been studied in the context of remyelination
202 ible Cre-lox system to study the function of TSC in the remyelination of a focal, lysolecithin-demyel
203     The current study examined the impact of TSC in rat models of ischemic and hemorrhagic stroke.
204    Here, we present the genomic landscape of TSC hamartomas.
205      Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulat
206 terations in a rat neuronal culture model of TSC.
207 on via similar mechanisms in mouse models of TSC.
208 mozygous mutant cells to the pathogenesis of TSC and the important role of p53 during reprogramming.
209 ted the role of HMGA2 in the pathogenesis of TSC using the TSC2(+/-) mouse model that similarly mirro
210  The mTOR-dependent, epithelial phenotype of TSC astrocytes suggests TSC1/2 and mTOR tune the phospho
211            With MFF considered predictive of TSC, 50% (24of 48) sensitivity, 100% (96 of 96) specific
212 describing the epidemiology and prognosis of TSC.
213                     Renal AMLs in setting of TSC may reach giant proportions and may present with mas
214 ent need for studies on optimal treatment of TSC.
215 d drugs that selectively affect viability of TSC-deficient cells, representing promising candidates f
216 e of grain-boundaries, the trap densities of TSCs are 10-100 folds lower than that of polycrystalline
217                Moreover, FGF4 deprivation of TSCs reduces geminin to a basal level that is required f
218 ng strategies have enabled the generation of TSCs from fibroblasts, opening up exciting new avenues t
219 erformed genome-wide expression profiling of TSCs, embryonic stem cells, epiblast stem cells, and mou
220                      We identified a role of TSCs in the regulation of inflammation during healing of
221 in ESCs but expressed on the cell surface of TSCs and trophoblast giant cells.
222 thesis have selective deleterious effects on TSC-deficient cells, including in mouse tumor models.
223         Therefore, haploinsufficiency of one TSC tumor suppressor gene was required for tumor initiat
224 last cells that have ceased to express other TSC genes such as Cdx2 and Eomes.
225 enuate LAM progression and potentially other TSC-related disorders.
226         Here, we have investigated the other TSCs, NSC319725 and NSC328784, identified in the same sc
227 tors based on CH3 NH3 PbBr3 and CH3 NH3 PbI3 TSCs show low noise of 1-2 fA Hz(-1/2) , yielding a high
228          Despite their epithelial phenotype, TSC astrocytes outgrew contact inhibition, and monolayer
229 %, but only 29% for the ones with a possible TSC diagnosis.
230 finite TSC, whereas another 7 had a possible TSC diagnosis.
231 ncertain whether mTOR inhibition can prevent TSC-associated renal tumourigenesis.
232                          Tuberous Sclerosis (TSC) also known as Bourneville disease is a neurocutaneo
233                          Tuberous sclerosis (TSC) is a tumor suppressor gene syndrome that is associa
234                          Tuberous sclerosis (TSC) is an inherited syndrome in which tumours in multip
235 2 complex (TSC1/2) cause tuberous sclerosis (TSC), a hereditary syndrome with neurological symptoms a
236        Importantly, Blimp1 not only silences TSC gene expression but also prevents aberrant activatio
237                                        Since TSC effectors are largely unknown in the human brain, TS
238 t anti-inflammatory roles of CTGF-stimulated TSCs that are likely associated with improved tendon hea
239 ame screen, as well as the more well studied TSC, 3-AP (Triapine), to determine whether they function
240 nxiety (STAI-T) and trauma-related symptoms (TSC-40) were collected; the disinhibition scale of the t
241 mTORC1 and development of the tumor syndrome TSC.
242         BMI was unrelated to BDI-II, STAI-T, TSC-40, or TFEQ scores.
243 sted the relationship between BD-II, STAI-T, TSC-40, TFEQ, CWIT, and BMI with correlation analyses.
244                            We determine that TSC lesions contain a low somatic mutational burden rela
245                                We found that TSC processes at hair follicles are tiled and that indiv
246          Moreover, our findings suggest that TSC has different functions in developmental myelination
247        Together, these findings suggest that TSC may be a safe and beneficial therapeutic modality fo
248                                          The TSC complex associates with the lysosome in a Rheb-depen
249 ng the spatial recruitment of mTORC1 and the TSC complex to Rheb at the lysosomal surface serve to in
250 ng mutations in either TSC1 or TSC2, and the TSC protein complex is an essential regulator of mTOR co
251                            When applying the TSC method to the motivating study above, the odds ratio
252        We found that BChE is anchored at the TSC by a proline-rich membrane anchor, the small transme
253                         alpha7 nAChRs at the TSC may act as a sensor for spillover of ACh adjusted by
254  gene products hamartin and tuberin form the TSC complex that acts as GTPase-activating protein for R
255 an their WT counterparts, resulting from the TSC inactivation.
256    This study provides new insights into the TSC transcriptomic network along with the identification
257 of CTGF from neurons, in turn, mitigates the TSC-dependent hypomyelination phenotype.
258 ean size, 31 mm +/- 24; range, 6-92 mm), the TSC of 69 mmol/kg +/- 10 was, on average, 49% higher tha
259 ke the existing methods, the validity of the TSC approach does not rely on any specific measurement e
260 lf5 are critical for normal expansion of the TSC compartment and embryonic survival, as Elf5 overexpr
261 lly suppresses lysosomal localization of the TSC complex and interaction with its target small GTPase
262 insulin stimulates acute dissociation of the TSC complex from the lysosomal surface, where subpopulat
263 hrough the Akt-dependent dissociation of the TSC complex from the lysosome.
264 roaches to investigate the complexity of the TSC molecular network.
265 plain the severe renal manifestations of the TSC/PKD contiguous gene syndrome and open new perspectiv
266 activation of alpha7 nAChRs localized on the TSC and activated by the spillover of ACh.
267             These findings indicate that the TSC/mTORC1/AKT/GSK3beta/beta-catenin/MITF axis plays a c
268                                      How the TSCs sense the synaptic activity in physiological condit
269 26 (ZMC1), belongs to the thiosemicarbazone (TSC) class of metal ion chelators that bind iron, copper
270 ed to uncover hyperphosphorylation unique to TSC primary astrocytes, the cell type affected in the br
271 romising candidates for repurposing to treat TSC-related tumors.
272 hypomethylated and expressed in trophoblast (TSCs) stem cells are very rare and may have particularly
273     Here we describe genetic findings in two TSC patients with multiple renal tumors, each of whom ha
274   Sox21 levels were high in undifferentiated TSCs and were dramatically reduced upon differentiation.
275 tism spectrum disorder (ASD) associated with TSC and fragile X syndrome.
276             MFF presence was associated with TSC gene mutations and with brain or multiorgan involvem
277  the electrographic seizures associated with TSC.
278     Despite its oncogenic effect, cells with TSC deficiency were more sensitive to oxidative stress a
279 e report a case of a 36-year-old female with TSC presenting as massive hematuria with underlying gian
280                          By interfering with TSC-Rheb complex, arginine relieves allosteric inhibitio
281                         Being a patient with TSC was associated with a hazard ratio of 2.1 for death
282 m hypomelanotic macules from 6 patients with TSC all exhibited reduced TSC2 protein expression, and 1
283                                Patients with TSC and control subjects were identified from the Swedis
284                     After four patients with TSC and unknown mutational status (two with MFF) were ex
285 ion, and 12% (one of eight) of patients with TSC but without an identified mutation (P = .044).
286 nist agents was more common in patients with TSC compared with either of the control groups.
287                                Patients with TSC develop hypomelanotic macules (white spots), but the
288                                Patients with TSC were characterized by a low cardiovascular risk fact
289 raphy was performed; 104 adult patients with TSC were enrolled in an observational cohort study that
290  risk markers and mortality in patients with TSC with that of individuals with or without coronary ar
291 rmal fibroblasts obtained from patients with TSC.
292 oid cell tumors (PEComas) from patients with TSC.
293 e of connective tissue nevi in patients with TSC.
294  detected in 50% (24 of 48) of patients with TSC; however, no MFF was detected in control patients (P
295                       Delayed treatment with TSC reduced infarct volume in a rodent model of transien
296  (median [range] age, 42 [19-70] years) with TSC (56%) had at least 1 connective tissue nevus on the
297 and 96 age- and sex-matched patients without TSC who had undergone chest CT were evaluated.
298    Sporadic LAM can develop in women without TSC, owing to somatic mutations in the TSC2 gene.
299 d for active chromatin characteristics in WT TSCs.
300              Unexpectedly, in wild-type (WT) TSCs these genes are transcribed and are enriched for ac

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top